EDITOR,-General practitioners recently received their latest reports giving prescribing
analysis and cost (PACT) data from the Prescription Pricing Authority. Traditionally these …

EDITOR,—Jeannette Naish and colleagues conclude that pressure to reduce the cost of
prescribing in asthma may lead to a lowering of the ratio of prophylactic to bronchodilator …

ED1rOR,-In addressing the controversy over the use of 13 agonists in asthma neither AE
Tattersfield nor RW Fuller has really fuelled the debate.'Their arguments revolve around …

EDITOR—The publication of the pulmonary embolism prevention (PEP) trial has created
considerable interest in the medical and lay press about the optimal thromboprophylactic …

In last week's issue guidelines on the management of chronic persistent asthma in adults
were published. 1 The present article gives guidance on the management of acute severe …

Background Definition Asthma is characterised by dyspnoea, cough, chest tightness,
wheezing, variable airflow obstruction, and airway hyperresponsiveness. The diurnal …

The evidence that 2 agonists can have adverse effects comes from mortality and morbidity
studies. An epidemic of deaths from asthma occurred in the 1960s in countries, including the …

Despite the many recent advances in our understanding of asthma many questions remain
unanswered.'Asthma has been rediscovered as an inflammatory disease, and the nature of …

Editor—Dixon and Dewar's editorial welcomes the considerable injection of money
promised in the NHS plan and claims that the plan is true to the NHS's founding principles. 1 …

Objectives: To determine the patterns of preventive to reactive prescribing for asthma among
general practices in the City and East London Family Health Services Authority area and …